key: cord-0332086-nnqtul2h
authors: Gu, Y.; Low, J. M.; Tan, J. S. Y.; Ng, M. S. F.; Ng, L. F. P.; Shunmuganathan, B. D.; Gupta, R.; MacAry, P. A.; Amin, Z.; Lee, L. Y.; Lian, D. W. Q.; Shek, L. P.-C.; Zhong, Y.; Wang, L. W.
title: Immune and pathophysiologic profiling of antenatal COVID-19 in the GIFT cohort: A Singaporean case-control study.
date: 2022-04-23
journal: nan
DOI: 10.1101/2022.04.19.22273864
sha: 89007370b712bd94f85727149fc8f01467d72248
doc_id: 332086
cord_uid: nnqtul2h

Background COVID-19 has been a major public health threat for the past two years, with disproportionate effects on the elderly, immunocompromised, and pregnant women. While much has been done in delineating immune dysfunctions and pathogenesis in the former two groups, less is known about the disease's progression in expectant women and children born to them. To address this knowledge gap, we profiled the immune responses in maternal and child sera as well as breast milk in terms of antibody and cytokine expression and performed histopathological studies on placentae obtained from mothers convalescent from antenatal COVID-19. Methods and findings A total of 17 mother-child dyads (8 cases of antenatal COVID-19 and 9 healthy unrelated controls; 34 individuals in total) were recruited to the Gestational Immunity For Transfer (GIFT) study. Maternal and infant sera, and breast milk samples were collected over the first year of life. All samples were analyzed for IgG and IgA against whole SARS-CoV-2 spike protein, the spike receptor-binding domain (RBD), and previously reported immunodominant epitopes, with conventional ELISA approaches. Cytokine levels were quantified in maternal sera using multiplex microbead-based Luminex arrays. The placentae were examined microscopically. We found high levels of virus-specific IgG in convalescent mothers and similarly elevated titers in newborn children. Virus-specific IgG in infant circulation waned within 3-6 months of life. Virus-specific IgA levels were variable among convalescent individuals' sera and breast milk. Convalescent mothers also showed a blood cytokine signature indicative of a persistent pro-inflammatory state. Four placentae presented signs of acute inflammation marked by neutrophil infiltration even though >50 days had elapsed between virus clearance and delivery. Administration of a single dose of BNT162b2 mRNA vaccine to mothers convalescent from antenatal COVID-19 increased virus-specific IgG and IgA titers in breast milk. Conclusions Antenatal SARS-CoV-2 infection led to high plasma titres of virus-specific antibodies in infants postnatally. However, this was not reflected in milk; milk-borne antibody levels varied widely. Additionally, placentae from COVID-19 positive mothers exhibited signs of acute inflammation with neutrophilic involvement, particularly in the subchorionic region. Virus neutralisation by plasma was not uniformly achieved, and the presence of antibodies targeting known immunodominant epitopes did not assure neutralisation. Antibody transfer ratios and the decay of transplacentally transferred virus-specific antibodies in neonatal circulation resembled that for other pathogens. Convalescent mothers showed signs of chronic inflammation marked by persistently elevated IL17RA levels in their blood. A single dose of the Pfizer BNT162b2 mRNA vaccine provided significant boosts to milk-borne virus-specific antibodies, highlighting the importance of receiving the vaccine even after natural infection with the added benefit of enhanced passive immunity. The study is registered at clinicaltrials.gov under the identifier NCT04802278.

System, Singapore 22 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022.

pro-inflammatory state. Four placentae presented signs of acute inflammation marked by neutrophil 48 infiltration even though >50 days had elapsed between virus clearance and delivery. Administration of 49 a single dose of BNT162b2 mRNA vaccine to mothers convalescent from antenatal COVID-19 50 increased virus-specific IgG and IgA titers in breast milk. 51 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint 5 against specific infections through their antigen specificity. These maternal antibodies comprise of 76 approximately 90% immunoglobulin A (IgA), 8% IgM and 2% IgG [4] . SARS-CoV-2 antibodies from 77 convalescent COVID-19 plasma have been extensively studied as a therapeutic option against COVID-78 19 infection [5, 6] . Several studies have also reported the presence of SARS-CoV-2 antibodies in the 79 BM of convalescent COVID-19 mothers [7] [8] [9] . However, the durability of those antibodies in the BM 80 and the mechanism of protection remains incompletely known. Hence, we sought to evaluate the 81 durability and neutralization capacity of SARS-CoV-2 specific IgG and IgA in the BM of convalescent 82 COVID-19 mothers. 83

Here, we report that natural infection of pregnant women by SARS-CoV-2 induced antibody 84 production and secretion into maternal blood and milk. However, plasma antibody titres were not 85 closely reflected by that in milk. Placentae from COVID-19 positive mothers exhibited signs of acute 86 inflammation with neutrophilic involvement, despite virus clearance in the nasopharynx. Virus 87 neutralisation by plasma was not uniformly achieved, despite high levels of antibodies targeting the 88 spike protein and its receptor-binding domain; the presence of antibodies targeting known 89 immunodominant epitopes did not assure neutralisation. Antibody transfer ratios and decay kinetics of 90 virus-specific antibodies in neonatal circulation largely resembled that described for other pathogens. 91

Targeted analysis of blood cytokines revealed significant elevations in IL17RA levels in convalescent 92 mothers' blood at 16 weeks (range 13-48) from the initial COVID-19 infection, indicating chronic 93 inflammation. Importantly, we also found that a single regular dose of the Pfizer BNT162b2 mRNA 94 vaccine given postnatally boosted milk-borne virus-specific IgG and IgA in mothers convalescent 95 from antenatal COVID-19. 96

This study was approved by the National Healthcare Group Institutional Review Board (Gestational 99 Immunity For Transfer GIFT: DSRB Reference Number: 2020/00483). Written informed consent was 100 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint Blood processing for plasma 114 Venous blood samples from the infant were collected at 0-3 days, 1 month, and 3 months of life, and 115 from the mothers at 1 month postpartum, in BD Vacutainer cell preparation tubes (BD, #362753). The 116 plasma fraction was harvested after centrifugation at 1500rpm, 5 minutes at 4 o C and stored at -80 o C. 117

Sample viral inactivation was performed by treatment with 1% Triton X-100 (Thermo Fisher Scientific, 118 #28314) and 0.3% (w/w) tri-(n-butyl) phosphate (TNBP) at room temperature for 2 hours. 119

120 spike protein 121 SARS-CoV-2 spike and RBD were generously provided by the Antibody Engineering Programme, Life 122

Sciences Institute, NUS as described previously [10] . 123 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

The PVNT assay was conducted as described previously [11] . Briefly, the ACE2 stably expressed CHO 140 cells were cultured at 5 × 10 4 /mL cells in complete medium for 24 hours. 80-times diluted plasma were 141 incubated with 50,000 lentiviral particles (representative of the SARS-CoV-2 Wuhan-Hu-1 strain) in a 142 total volume of 50 µL at 37 °C for 1 hour. This mixture was added to the CHO-ACE2 monolayer cells 143 and left incubated for 1 hour to allow pseudotyped viral infection. Subsequently, complete medium was 144 added at 150 µL/well for further incubation of 48 hours. After two washes with PBS, 100 µL of ONE-145 gloTM EX luciferase assay reagent (Promega, #E8130) was added to each well and the luminescence 146 values were recorded. The percentage neutralization was calculated as follows: 147

CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint incubated with the cytokine-bound beads for an hour. Streptavidin-PE was then added for another 30 174 mins before the acquisition of data using xPONENET ® 4.0 (Luminex Corporation, USA) software. Data 175 was analysed using the Bio-Plex Manager TM 6.1.1. Standard curves were generated with a 5-PL (5-176 parameter logistic) algorithm, reporting values of median fluorescence intensity (MFI) and 177 concentration data. 178

Real time reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19 PCR swabs were 179 obtained from amniotic fluid, umbilical cord, placental, umbilical cord blood, maternal blood and high 180 vaginal swabs and breast milk [15, 16] . 181

The placenta specimen was fixed in formalin overnight before representative sections were obtained 182 from the umbilical cord, placental membranes and placental disc. The tissue was subsequently 183 processed and stained with hematoxylin and eosin for microscopic examination. Eight women with a diagnosis of laboratory confirmed COVID-19 during pregnancy participated in the 192 study (S1 Table) . Nine women with no antenatal COVID-19 were recruited as controls. On average, 193 COVID-19 convalescent women were 30.3 ± 2.4 years old. Additional characteristics of the study 194 participants and their infants are presented in Table 1 . Of the 8 women, 6 had mild COVID-19, with the 195 most common being dry cough, sore throat and malaise, with one having moderate COVID-19 and the 196 remaining person being asymptomatic. None of them progressed towards hypoxia or exhibited signs of 197 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. Mixed feeding 2 0

The eight infants were all born full term with mean gestational age (SD) of 39 ± 2 weeks and had a 206 mean birth weight (SD) of 3.517 ± 0.261 kg. One infant required neonatal intensive care unit stay for 2 207 days for transient tachypnea of the newborn and was given supplemental oxygen therapy. All infants 208

were breastfed up to 3 months, two of whom were supplemented with formula milk during the same 209 period. CS03, CS07) showed signs of acute inflammation (Fig 1) . Neutrophils were seen in the subchorionic 216 fibrin, indicating subchorionitis. There was no spread of the neutrophils into the chorion or amnion. A 217 mild corresponding foetal inflammatory response was also seen in the umbilical arteries and veins of 218 one of the placentas (CS03). The placenta of CS05 had signs of maternal-foetal malperfusion, and this 219 placenta was also hypoplastic at 389g at 38+0 weeks gestation). However, CS05 had concomitant 220 gestational diabetes mellitus. 221 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We first confirmed the presence of IgG antibodies targeting SARS-CoV-2 spike protein (Fig 2A) and 230 spike protein RBD (Fig 2B) in all mothers' plasma 1-month post-partum. Plasma IgA antibodies 231 targeting the same antigens were expressed more variably; they were detected in ~50% of the 232 convalescent mothers (Fig 2C, D) . 233 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Most convalescent maternal plasma were able to neutralize SARS-CoV-2 pseudoviruses, albeit to 243 varying extents (Fig 3) . Interestingly, plasma from one mother -CS04 -showed no detectable 244 pseudovirus neutralizing ability despite spike-and RBD-specific IgG antibodies being present and 245 comparable to other convalescent mothers. These antibodies are likely to confer some degree of 246 protection against SARS-CoV-2 infections. It is worth noting that neutralization capacity did not 247 correlate with the length of time between disease resolution and point of sampling. In other words, the 248 women who were infected at an earlier stage of pregnancy did not necessarily produce lower titers as 249 one would expect due to antibody decay and contraction of the humoral response. 250 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. Four immunodominant epitopes S14P5, S20P2, S21P2 and N4P5 were previously identified to be 257 associated with disease severity in adults (age 41 ± 13, years ± standard deviation) [12] . Importantly, 258 antibodies against S14P5 and S21P2 epitopes were able to neutralize SARS-CoV-2-infection 259

[12,13,20]. Hence, we evaluated the presence of antibodies against the four immunodominant epitopes 260 in our cohort. A significant increase in the levels of IgG against S21P2 (Mann Whitney, two tailed, 261 p=0.0205) was observed in the plasma of convalescent mothers compared to controls (S1 Fig C) . No 262 significant difference in the levels of IgG against the other three immunodominant epitopes in the 263 plasma of convalescent mothers compared to controls was found (S1 Fig A, B, and D) . The IgA levels 264 against the four immunodominant epitopes in convalescent mothers were mostly below the limit of 265 detection. Hence differences in IgA levels in the plasma between both groups cannot be accurately 266 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint An important component of passive immunity is the suite of antibodies transferred across the placenta 270 from mother to child. As shown in Fig 4A and B , compared to the mothers, SARS-CoV-2 specific IgG 271 antibodies were detected in the infants' sera at comparable or higher levels at birth, showing passive 272 immunity to be successfully transferred via the placenta. We observed a steady decrease in plasma IgG 273 levels in infants from birth to 6 months of age, where the signal approached the lower detection limit. 274

The transplacental transfer ratios for spike-and RBD-specific IgG antibodies ranged from 0.73 to 1.4 275 6 ( Fig 4C and D) , in alignment with previous COVID-19 studies and other types of pathogens [21] [22] [23] . 276 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. We noted a singular case, CS04, who produced S21P2-specific IgA responses in plasma and milk that 302 were significantly higher than others, with no decrease observed up to 3 months postpartum (S2 Fig C,  303   S3 Fig C) . Notably, CS04 suffers from chronic high-viral load hepatitis C virus (HCV) infection, where 304 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint 20 the virus is of genotype GT3a. CS04 did not have unusually high serum IgA (Fig 2C and D) . Hence, 305

we asked the question whether HCV genotype GT3a encodes S21P2-like antigens that could induce 306 cross-reactive antibody production. Initial Protein BLAST revealed no significant overlap between 307 S21P2 and HCV proteins, including those encoded by GT3a (S1 Appendix). We then compared CS04 308 against CT10, a control mother who was COVID-19-negative but was HCV genotype GT3a-positive 309

with comparable viral loads. Unlike CS04, CT10 did not have any pre-existing antibodies against S21P2 310 (S2 Fig C, S3 Fig C) . This suggests that the high titers of S21P2-specific IgA in CS04 were not due to 311 cross-reactive IgA-mediated immunity against HCV. It might be that carriage of HCV results in a 312 stronger mucosa-directed anti-viral response marked by higher titers of anti-S21P2 IgA. Nonetheless, 313

we acknowledge the key limitation of small sample size, given the rarity of co-infections by SARS-314

CoV-2 and HCV in pregnant women; larger studies will be required to clarify interactions or lack 315 thereof between the two viruses. 316

To gain insight on long-term perturbations in the maternal immune system post-COVID 19, we 318 quantified levels of cytokines with a 41-plex microbead-based immunoassay. Using plasma samples of 319 six control and seven convalescent mothers at 1-month post-partum, we could detect 33 out of 41 320 cytokines (Fig 6) . As far as the assayed cytokines were concerned, both healthy and convalescent 321 mothers had largely similar signatures. Most of the signals for the detected cytokines were not 322 distributed normally, likely due to the fact that they clustered near the lower limit of detection. 323

Notwithstanding, five cytokines, namely interleukin-17RA (IL-17RA), eotaxin, interferon-gamma 324 produced protein-10 (IP-10), monocyte chemoattractant protein-1 (MCP-1) and macrophage 325 inflammatory protein-1β (MIP-1β) exhibited Gaussian distributions and were likely more robust 326 biomarkers. Hence, we focused on these cytokines for further analysis. In order to detect cytokines with 327 increased expression in convalescent mothers, we utilized a statistical threshold of p<0.1 due to small 328 sample size and low power in this study. We found that pro-inflammatory cytokines IL-17RA (p=0.02) 329

and MCP-1 (p=0.0766) were elevated in convalescent mothers than healthy controls, suggestive of a 330 prolonged inflammatory state long after COVID resolution (Fig 6B and C) . 331 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint Given the observation that IgG transferred via the placenta only lasted for about 6 months in the 343 infant, and the scarcity of SARS-CoV-2 specific antibodies in convalescent milk, we investigated 344 alternative methods of passive immunity to protect infants from potential SARS-CoV-2 infection. 345

Three convalescent mothers from our original cohort who were still nursing were given one dose of 346 the BNT162b2 (Pfizer/BioNTech) mRNA vaccine. BM was taken at 4 time points, namely before 347 vaccination, 3 days post-vaccination (PV), 7 days PV and 30 days PV. SARS-CoV-2 specific 348 antibodies were not detectable in milk before vaccination. At 7-30 days PV, both SARS-CoV-2 349 specific IgG and IgA were generally detected at much higher levels (Fig 7) , although CS11 did not 350 secrete detectable levels of RBD-specific IgA into her milk (Fig 7B) . In this study, we show that women who had acquired COVID-19 during pregnancy have high levels 360 of circulating virus-specific IgG in their blood relative to control mothers. Furthermore, spike-and 361 RBD-specific IgG levels in maternal circulation were maintained at relatively high levels regardless 362 of gestation when SARS-CoV-2 infection was acquired in pregnancy; virus-specific IgG could be 363 detected in infants at birth when mothers had acquired antenatal COVID-19 as early as 15 weeks. 364

However, circulating spike-and RBD-specific IgG levels in infants born to convalescent COVID-19 365 mothers declined to negligible levels by three months of life. These findings are all consistent with the 366 known patterns of acute gestational infections and passive immunity. 367

While virus-specific IgG was robustly expressed in convalescent plasma, virus-specific IgA levels in 368 the blood were far more variable. IgA is a marker of acute infection and wanes just as IgG expression 369 starts to pick up during disease resolution [24, 25] . Hence, the expectation is that the shorter the 370 interval between virus clearance and the point of sampling, the higher the IgA titers measured at the 371 time of sample collection. We did not see such a clear pattern, which may be due to our small sample 372 size and other factors related to host genetics and the environment that may modulate the plasma IgA 373

It is worth noting that, of the placental samples examined, CS02, CS03 and CS07 showed up 375 abnormal findings indicative of acute inflammation, more than 50 days after their nasopharyngeal delivery. Interestingly, the four convalescent mothers whose placentae showed abnormal 384 characteristics also showed the lowest titers of virus-specific IgA in their blood. Plasma IgA is 385 predominantly monomeric and capable of engaging FcαRI (also known as CD89) on myeloid cells, 386

presumably to trigger the first line of anti-viral defense. One may speculate that placental 387 granulocytes perform a largely sentinel role to prevent compromise of the placental barrier, and in the 388 absence of high amounts of plasma IgA indicative of active infection, they might be continually and 389 preferentially mobilized to the placenta leading to low levels in the circulation [28] . 390

Inefficient transplacental antibody transfer has been previously reported in a small cohort study of 391 COVID-19 mothers [22] . However, we did not see this particular effect in our cohort, even in the 392 mothers who acquired COVID-19 in the third trimester and whose placentae exhibited signs of 393 inflammation and potential tissue damage. These discrepancies might be due to differences in severity 394 stratification (ratio of asymptomatic: mild: moderate: severe was 6:9:3:4 in Atyeo et al. In our study, we noted a significant elevation of IL-17RA and a trend of increased MCP-1 in 400 convalescent mothers relative to controls (Fig 6B and C) . IL-17RA is a soluble receptor of IL-17A, 401 thereby preventing the latter's association with cell surface receptors. IL-17A has been implicated in 402 SARS-CoV-2 pathogenesis with elevated peripheral IL-17 levels and Th17 infiltration in the lungs of 403 COVID patients [30, 31] . The persistence of IL-17A together with other inflammatory cytokines such 404 as IL-12p70, stem cell factor, and IL-1β was discovered in patients up to 180 days post-infection [32] . 405

In agreement with our findings, COVID-19 patients were found to have increased IL-17RA levels 406 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint and Immunology, Yong Loo Lin School of Medicine, NUS for the ACE2 stably expressing CHO cells 494 and plasmid encoding SARS-CoV-2 S protein for the pseudotyped lentiviral production. We thank the 495 participating mothers and children for their kind donation of samples. 496 497 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint

Epidemiological characteristics of 2143 pediatric patients with 2019 499 coronavirus disease in China

A review of 502 newborn outcomes during the COVID-19 pandemic

Innate Immunity and Breast Milk

Human Milk Immunoglobulin Survival during Gastric Digestion between Preterm and Term Infants

Dynamics and 509 significance of the antibody response to SARS-CoV-2 infection. medRxiv : the preprint server for 510 health sciences

Clinical infectious diseases : an official publication 513 of the Infectious Diseases Society of America

Antibodies in the breast milk of a 515 maternal woman with COVID-19. Emerging microbes & infections

Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk. iScience

Clinical and immunologic features 520 among COVID-19-affected mother-infant pairs: antibodies to SARS-CoV-2 detected in breast milk

New microbes and new infections

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

CoV-2 S protein:ACE2 interaction reveals novel allosteric targets. eLife. 2021;10

A rapid 525 simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies

Linear B-cell epitopes in 528 the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity

Two linear epitopes 531 on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir

Clinical features of patients infected 537 with 2019 novel coronavirus in Wuhan

A familial cluster of pneumonia 539 associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a 540 family cluster

No obviously adverse pregnancy 542 complications and outcomes of the recovered pregnant women from COVID-19

A structured review 545 of placental morphology and histopathological lesions associated with SARS-CoV-2 infection

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-549 analysis

Viral epitope profiling of 551

COVID-19 patients reveals cross-reactivity and correlates of severity

Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer 555

Compromised 557 SARS-CoV-2-specific placental antibody transfer

Placental antibody transfer efficiency and 559 maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-560 1 antibodies

-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection

Serum IgA, IgM, and IgG responses in 565 COVID-19

Placental Pathology of COVID-19 with and without Fetal and 567

Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for 568

Transplacental Transmission of SARS-CoV-2. Viruses

Findings during and after SARS-CoV-2 Infection: Features of Villitis and Malperfusion

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

SARS-CoV2 vertical 573 transmission with adverse effects on the newborn revealed through integrated immunohistochemical, 574 electron microscopy and molecular analyses of

associated with acute respiratory distress syndrome. The Lancet Respiratory medicine

COVID-19: a case for inhibiting IL-17?

Persistent Symptoms 584 and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease

Open forum infectious diseases

Immunocytometric 587 analysis of COVID patients: A contribution to personalized therapy?

Journal of interferon & cytokine research : the official journal of the International 590 Society for Interferon and Cytokine Research

Higher expression of monocyte chemotactic 592 protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling

during the acute phase, especially in those with milder symptoms [33] . Hence, enhanced IL-17RA 407 may have a protective role in limiting the downstream effects of IL-17; elevated IL-17RA levels may 408 be a prognostic marker of mild disease in pregnant and lactating women. MCP-1 is the other cytokine 409 that was slightly elevated in convalescent mothers relative to control mothers. It is produced by 410 monocytes and macrophages to regulate the migration and infiltration of natural killer cells, 411 monocytes, and T cells [34] . Greater MCP-1 expression characterizes patients with mild COVID-19, 412suggestive of potential roles in mitigating severity [35] . However, we note that the lack of severe 413 cases in our cohort limits us from investigating whether high IL-17RA and MCP-1 levels are true 414 predictors of mild disease. 415In breast milk, low levels of spike-specific IgG were secreted into 2 out of 8 convalescent women's 416 BM. This is consistent with the existing dogma that IgG is rarely released into milk; the dominant 417 isotype is IgA. Even so, virus-specific IgA was only present in a subset of convalescent mothers' milk 418samples. This is somewhat expected as IgA levels are not maintained throughout infection and have 419 been found to be lowest on the outset in mild cases, where most of the subjects in our cohort fall 420We further delineated the humoral response to linear B cell epitopes that have been previously 422 described to be immunodominant. There are certain advantages in investigating these epitopes instead 423 of conformational ones -(1) the system is considerably cheaper to set up for further validation 424 studies, and (2) it is easier to prime cells with peptides which can be synthesized conveniently and do 425 not require complex purification and refolding protocols. We found that most linear epitopes were 426generally not well-recognized by antibodies present in sera and milk from convalescent mothers. This 427 might be due to the fact that long periods of time had passed between COVID-19 recovery and 428 sampling points; the antibody levels waned, similar to that for other infections. One notable exception 429 is S21P2, where epitope-specific IgG was significantly elevated in convalescent plasma compared to 430 controls. In particular, CS04 produced extremely high levels of S21P2-specific IgA in the BM by 431 mechanisms unknown to us, although preliminary analysis has excluded HCV antigen cross-reactivity 432 as one possible factor. Nonetheless, much of these signals were non-specific and could also be 433 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint 26 detected in controls who had non-SARS-CoV-2 coronavirus infection or non-coronavirus antenatal 434

Given that convalescent sera do contain high levels of spike-and RBD-specific IgG and yet exhibit 436 low, variable neutralization capacities, we infer that most of the IgG are poorly functional in terms of 437 blocking receptor binding, which is consistent with a previous report showing low neutralizing 438 antibody titers in mild cases [36] . The current design of the mRNA vaccines utilizes the 2P mutated 439 spike to stabilize its pre-fusion conformation. As these convalescent women had not received the A key limitation of our study is the cohort size. Most of our samples were collected early on in the 456 pandemic before Singapore introduced a slew of effective public health measures to stymie the spread 457 of the virus, including travel restrictions, social distancing, and a lockdown. Due to this unique 458 situation, relatively few people were infected in the first wave from April to August 2020. Limited 459 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 23, 2022. We thank Antibody Engineering Programme, Life Sciences Institute, NUS for providing the purified 492 spike protein and RBD. We thank Associate professor Tan Yee Joo from Department of Microbiology 493 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted April 23, 2022. ; https://doi.org/10.1101/2022.04.19.22273864 doi: medRxiv preprint